Reddoch James F.
Insider CIK 1814872 · RPRX EVP, Research & Investments
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RPRX Royalty Pharma plc | S Sale | 2022-09-28 | 2022-09-30 | 100,000 | $41.23 | $4.12M | 820,800 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2022-08-12 | 2022-09-30 | 2,400 | — | $0 | 478,870 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-06-08 | 2022-06-10 | 100,000 | $41.56 | $4.16M | 920,800 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-05-27 | 2022-05-31 | 75,000 | $41.08 | $3.08M | 1,020,800 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-05-19 | 2022-05-23 | 75,000 | $40.44 | $3.03M | 1,095,800 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2021-09-10 | 2021-12-30 | 5,128 | — | $0 | 481,270 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-26 | 2021-07-27 | 8,949 | $39.78 | $356.0K | 1,170,800 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-26 | 2021-07-27 | 8,949 | $39.78 | $356.0K | 1,170,800 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-14 | 2021-07-14 | 2 | $42.00 | $84 | 1,179,749 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-13 | 2021-07-14 | 17,832 | $42.01 | $749.1K | 1,179,751 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-12 | 2021-07-14 | 100 | $42.04 | $4.2K | 1,197,583 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-08 | 2021-07-08 | 40,655 | $42.05 | $1.71M | 1,197,683 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-07 | 2021-07-08 | 2,192 | $42.01 | $92.1K | 1,238,338 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-06 | 2021-07-08 | 30,270 | $42.40 | $1.28M | 1,240,530 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-08 | 2021-06-08 | 50,000 | $46.43 | $2.32M | 1,270,800 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-07 | 2021-06-08 | 2,210 | $47.01 | $103.9K | 1,320,800 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-07 | 2021-06-08 | 47,790 | $46.57 | $2.23M | 1,323,010 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-04 | 2021-06-08 | 100,000 | $44.60 | $4.46M | 1,370,800 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-02 | 2021-06-04 | 50,000 | $42.13 | $2.11M | 1,470,800 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2021-05-07 | 2021-05-11 | 132,080 | — | $0 | 486,398 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2021-05-07 | 2021-05-11 | 1,320,800 | — | $0 | 1,520,800 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-04-14 | 2021-04-16 | 55,714 | $42.10 | $2.35M | 200,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-04-12 | 2021-04-14 | 359 | $42.32 | $15.2K | 255,714 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-22 | 2021-03-24 | 43,927 | $46.32 | $2.03M | 256,073 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-02 | 2021-03-04 | 3,510 | $47.84 | $167.9K | 300,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-02 | 2021-03-04 | 96,490 | $46.89 | $4.52M | 303,510 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-12-31 | 2021-01-05 | 27,010 | — | $0 | 2,107 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-12-31 | 2021-01-05 | 12,990 | — | $0 | 618,478 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-12-31 | 2021-01-05 | 129,900 | — | $0 | 400,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-12-31 | 2021-01-05 | 270,100 | — | $0 | 270,100 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-06-18 | 2020-06-22 | 2,503 | — | $0 | 195 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-06-18 | 2020-06-22 | 25,030 | — | $0 | 25,030 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 631,468 | — | $0 | 631,468 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 29,117 | — | $0 | 29,117 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 2,698 | — | $0 | 2,698 | SEC↗ |